1 |
K. W. Jung, Y. J. Won, C. M. Oh, H. J. Kong, D. H. Lee, and K. H. Lee, "Cancer statistics in korea: incidence, mortality, survival, and prevalence in 2014," Cancer research and Treatment, Vol.49, No.2, pp.292-305, 2017.
DOI
|
2 |
Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, M. J. Daly, and R. E. Henly, "Epidemiology of hepatocellular carcinoma in the asia-pacific region," Gut Liver, Vol.10, No.3, pp.332-339, 2016.
|
3 |
S. K. Yoon and H. G. Chun, "Status of hepatocellular carcinoma in south korea," Chin Clin Oncol, Vol.2, No.4, p.39, 2013.
|
4 |
E. Y. Lee, T. T. Xuan Mai, Y. J. Chang, and M. R. Ki, "Trends of liver cancer and its major risk factors in korea," Epidemiol Health, Vol.37, p.e2015016, 2015.
DOI
|
5 |
Robert G. Gish, Richard S. Finn, and Jorge A. Marrero, "Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma," Gastroenterol Hepatol, Vol.9, No.4, suppl.2, pp.1-24, 2013.
|
6 |
Josep M. Llovet, Maria Isabel Real, Xavier Montana, Ramon Planas, Susana Coll, John Aponte, Carmen Ayuso, Margarita Sala, Jordi Muchart, Ricard Sola, Joan Rodes, and Jordi Bruix, "Arterial embolisation or chemoembolisation versus symptomatic," Lancet, Vol.359, pp.1734-1739, 2002.
DOI
|
7 |
Gerald D. Dodd, Michael C. Soulen, Robert A. Kane, Tito Livraghi, William R. Lees, Yasuyuki Yamashita, Alison R. Gillams, Okkes I. Karahan, and H. C. Rhim, "Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough," Radiographics, Vol.20, pp.9-27, 2000.
DOI
|
8 |
D. G. Farmer, M. H. Rosove, A. Shaked, and R W. Busuttil, "Current treatment modalities for hepatocellular carcinoma," Ann Surg, Vol.219, pp.236-247, 1994.
DOI
|
9 |
F. F. Haddad, W. C. Chapman, J. K. Wright, T. K. Blair, and C. W. Pinson, "Clinical experience with cryosurgery for advanced hepatobiliary tumors," J Surg Res., Vol.75, pp.103-108, 1998.
DOI
|
10 |
Eric C. Ehman, Geoffrey B. Johnson, Javier E. Villanueva-Meyer, S. M. Cha, Andrew Palmera Leynes, Peder Eric Zufall Larson, and Thomas A. Hope, "PET/MRI: Where might it replace PET/CT?," J Magn Reson Imaging, doi:10.1002/jmri.25711, 2017.
DOI
|
11 |
Felix Nensa, Karsten Beiderwellen, Philipp Heusch, and Axel Wetter, "Clinical applications of PET/MRI: current status and future perspectives," Diagn Interv Radiol, Vol.20, No.5, pp.438-447, 2014.
DOI
|
12 |
W. Atkinson, C. Catana, J. S. Abramson, G. Arabasz, S. McDermott, O. Catalano, V. Muse, M. A. Blake, J. Barnes, M. Shelly, E. Hochberg, B. R. Rosen, and A. R. Guimaraes, "Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients," Abdom Radiol, Vol.41, pp.1338-4138, 2016.
DOI
|
13 |
K. Beiderwellen, M. Huebner, P. Heusch, J. Grueneisen, V. Ruhlmann, F. Nensa, H. Kuehl, L. Umutlu, S. Rosenbaum-Krumme, and T. C. Lauenstein, "Whole-body [ ]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results," Eur Radiol., Vol.24, No.8, pp.2023-2030, 2014.
DOI
|
14 |
C. M. Tempany, J. Jayender, T. Kapur, T. Kapur, R. Bueno, A. Golby, N. Agar, and F. A. Jolesz, "Multimodal imaging for improved diagnosis and treatment of cancers," Cancer, Vol.121, pp.817-827, 2015.
DOI
|
15 |
Toshio Wagai, "Studies on the foundation and development of diagnostic ultrasound," Proc Jpn Acad Ser B Phys Biol Sci., Vol.83, No.8, pp.256-265, 2007.
DOI
|
16 |
A. Samarin, M. Hullner, M. A. Queiroz, P. Stolzmann, I. A. Burger, G. Von Schulthess, and P. Veit Haibach, " -FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with -FDG-PET/CT," Nucl Med Commun., Vol.36, No.12, pp.1165-1173, 2015.
DOI
|
17 |
Kathy Schilling, Deepa Narayanan, Judith E. Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, and Larraine Chrystal, "Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging," Eur J Nucl Med Mol Imaging, Vol.38, No.1, pp.23-36, 2011.
DOI
|
18 |
K. Beiderwellen, L. Geraldo, V. Ruhlmann, P. Heusch, B. Gomez, F. Nensa, L. Umutlu, and T. C. Lauenstein, "Accuracy of [ ]FDG PET/MRI for the detection of liver metastases," PLoS ONE, Vol.10, No.9, p.e0137285, 2015.
DOI
|
19 |
Philipp Heusch, Felix Nensa, Benedikt Schaarschmidt, Rupika Sivanesapillai, Karsten Beiderwellen, Benedikt Gomez, Jens Kohler, Henning Reis, Verena Ruhlmann, and Christian Buchbender, "Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncolog," Eur J Nucl Med Mol Imaging, Vol.42, No.1, pp.42-48, 2015.
DOI
|
20 |
Ali Civelek, Anshuma Rana, Ashkan Malayeri, Justin Rodante, Amit Dey, Nehal Mehta, and David Bluemke, "PET-MRI derived 18F-FDG liver SUV metrics: effects of hepatic steatosis and comparison with PET-CT," J Nucl Med., Vol.58, No.1, p.455, 2017.
|
21 |
Ahmet Mert, Niyazi Kilic, Erdem Bilgili, and Aydin Akan, "Breast cancer detection with reduced feature set," Comput Math Methods Med., doi:10.1155/2015/265138, 2015.
DOI
|
22 |
A. Marcano-Cedeno, Paloma Chausa, Alejandro Garcia, Cesar Caceres, Josep M. Tormos, and Enrique J. Gomez, "Data mining applied to the cognitive rehabilitation of patients with acquired brain injury," Exp Sys Appl., Vol.40, No.4, pp.1054-1060, 2013.
DOI
|
23 |
Dushyant V. Sahani and Sanjeeva P. Kalva, "Imaging the liver," The Oncologist, Vol.9, No.4, pp.385-397, 2004.
DOI
|
24 |
Claudio Spick, Ken Herrmann, and Johannes Czernin, " -FDG PET/CT and PET/MRI perform equally well in cancer: evidence from studies on more than 2,300 Patients," J Nucl Med, Vol.57, No.3, pp.420-430, 2016.
DOI
|
25 |
Bing Bai, Quanzheng Li, and Richard M. Leahy, "MR guided PET image reconstruction," Semin Nucl Med., Vol.43, No.1, pp.30-44, 2014.
DOI
|
26 |
Ahmedin Jemal, Freddie Bray, Melissa M. Jacques Ferlay, Elizabeth Ward, and David Forman, "Global cancer statistics," Ca cancer J Clin., Vol.61, pp.69-90, 2011.
DOI
|
27 |
Ruben Hernaez, Mariana Lazo, Susanne Bonekamp, Ihab Kamel, Frederick L. Brancati, Eliseo Guallar, and Jeanne M. Clark, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis," Hepatology, Vol.54, No.3, pp.1082-1090, 2011.
DOI
|
28 |
Eldad S. bialecki and Adrian M. Di Bisceglie, "Diagnosis of hepatocellular carcinoma," HPB(Oxford), Vol.7, No.1, pp.26-34, 2005.
DOI
|
29 |
A. Abbasi, A. R. Bhutto, N. Butt, and S. M. Munir, "Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma," J Pak Med Assoc, Vol.62, No.1, pp.33-36, 2012.
|
30 |
Marialuigina Fruscella, Antonio Ponzetto, Annalisa Crema, and Guido Carloni, "The extraordinary progress in very early cancer diagnosis and personalized therapy: the role of oncomarkers and nanotechnology," J Nanotech, doi:10.1155/2016/3020361, 2016.
DOI
|
31 |
Andrew J. Vickers, "Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers," Am Stat., Vol.62, No.4, pp.314-320, 2008.
DOI
|
32 |
Peter R. Killeen, "Beyond statistical inference: A decision theory for science," Psychon Bull Rev., Vol.13, No.4, pp.549-562, 2006.
DOI
|